Previous Article | Next Article 
Journal of Virology, April 1999, p. 3219-3226, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Herpes Simplex Virus 1 Blocks
Caspase-3-Independent and Caspase-Dependent Pathways to Cell
Death
Veronica
Galvan,
Renato
Brandimarti, and
Bernard
Roizman*
The Marjorie B. Kovler Viral Oncology
Laboratories, The University of Chicago, Chicago, Illinois 60637
Received 11 November 1998/Accepted 23 December 1998
 |
ABSTRACT |
Earlier reports have shown that herpes simplex virus 1 (HSV-1)
mutants induce programmed cell death and that wild-type HSV blocks the
execution of the cell death program triggered by viral gene products,
by the effectors of the immune system such as the Fas and tumor
necrosis factor pathways, or by nonspecific stress agents such as
either osmotic shock induced by sorbitol or thermal shock. A report
from this laboratory showed that caspase inhibitors do not block DNA
fragmentation induced by infection with the HSV-1 d120
mutant. To identify the events in programmed cell death induced and
blocked by HSV-1, we examined cells infected with wild-type virus or
the d120 mutant or cells infected and exposed to sorbitol. We report that: (i) the HSV-1 d120 mutant induced apoptosis
by a caspase-3-independent pathway inasmuch as caspase 3 was not activated and DNA fragmentation was not blocked by caspase inhibitors even though the virus caused cytochrome c release and
depolarization of the inner mitochondrial membrane. (ii) Cells infected
with wild-type HSV-1 exhibited none of the manifestations associated with programmed cell death assayed in these studies. (iii) Uninfected cells exposed to osmotic shock succumbed to caspase-dependent apoptosis
inasmuch as cytochrome c was released, the inner
mitochondrial potential was lost, caspase-3 was activated, and
chromosomal DNA was fragmented. (iv) Although caspase-3 was
activated in cells infected with wild-type HSV-1 and exposed to
sorbitol, cytochrome c outflow, depolarization of the inner
mitochondrial membrane, and DNA fragmentation were blocked. We conclude
that although d120 induces apoptosis by a
caspase-3-independent pathway, the wild-type virus blocks apoptosis
induced by this pathway and also blocks the caspase-dependent pathway
induced by osmotic shock. The block in the caspase-dependent pathway
may occur downstream of caspase-3 activation.
 |
INTRODUCTION |
The studies described here are based
on three series of observations. First, in earlier studies this
laboratory reported that herpes simplex virus 1 (HSV-1) mutants induced
degradation of cellular DNA and morphologic changes characteristic of
programmed cell death (15). Specifically, cells infected
with a mutant (d120) lacking the major regulatory gene
coding infected cell protein 4 (ICP4) and exhibiting a defect in the
viral protein kinase encoded by the Us3 gene induced DNA
fragmentation in all cell lines tested to date. Another mutant,
tsB7, induced apoptosis in Vero cells but not in SK-N-SH
cells incubated at the nonpermissive temperature (10). Under
these conditions, tsB7 attaches and penetrates cells.
Although the capsid is transported to the nuclear pore, the DNA is
not released and viral gene expression does not ensue (2,
3). Both mutants, d120 and tsB7, are
blocked at very early, but distinct, stages in infection. In Vero cells
infected with tsB7 and maintained at the nonpermissive
temperature, the events prior to release of viral DNA into the nucleus
are sufficient to induce apoptosis; in both Vero and SK-N-SH cells
infected with d120, transcription and translation of a
subset of proteins that included the
proteins was required. These
observations led to the conclusion that HSV-1 can trigger apoptosis at
multiple steps in infection and that the virus encodes functions that
can block the execution of the death program induced by its presence in the infected cell.
The second observation reported from this and other laboratories was
that HSV-1 blocks programmed cell death induced by the effector
functions of the immune system such as the Fas and tumor necrosis
factor (TNF)-mediated pathways, as well as nonspecific inducers of
apoptosis such as thermal or osmotic shock (10-12). Last,
this laboratory reported the surprising finding that caspase inhibitors
failed to block the fragmentation of cellular DNA induced by
d120 and raised the possibility that the virus can induce
caspase-independent programmed cell death (10). The
objectives of the studies reported here were to verify the observation
that HSV-1 d120 induced caspase-independent programmed cell
death and to identify the steps in programmed cell death blocked by
wild-type HSV-1. Relevant to this report are the following.
(i) The pathways of programmed cell death comprise at least two
effector branches that converge upon the activation of the downstream
effector caspases such as caspase-3, -6, and -7 to cause the
degradation of specific cytoplasmic and nuclear proteins, the
fragmentation of chromosomal DNA, and ultimately the organized breakdown of the cell (reviewed in references 4 and
26). Activation of caspases, a family of cysteine
proteases, is central to this process and occurs through the
proteolytic cleavage of the proenzymes into their active, catalytic
forms. The zymogens of several different caspases have been shown to be
substrates for other members of the family and to be able to cleave
their own precursors. Thus, upon receipt of a death signal, a cascade of proteolytic cleavages results in activation of preexisting inactive
caspases that ultimately destroy the cell (reviewed in reference
5). For example, ligand-induced clustering of death receptors, such as Fas and TNF-R, initiate the execution of one of
these pathways, in which the caspase machinery is directly engaged
through the activation of caspase-8 (21, 22). Active caspase-8 cleaves and activates the downstream caspase effectors caspase-3, -6, and -7 (25). On the other hand,
stress-inducing stimuli (e.g.,
or UV light irradiation, inhibitors
of RNA polymerase, or the withdrawal of growth factors) have been shown
to initiate another converging pathway that is regulated by the Bcl-2
family of proteins (1). This pathway involves mitochondrial
events, such as the release of cytochrome c into the cytosol
and the dissipation of the voltage gradient across the inner
mitochondrial membrane. The presence of cytochrome c in the
cytoplasm results in the formation of a complex of cytochrome
c, Apaf-1, and procaspase-9. This complex activates
caspase-9, which in turn cleaves and activates caspase-3 (30). Activated caspase-3 recognizes and cleaves ICAD/CAD
DNA fragmentation factor 45 (DFF45/ICAD), the inhibitory partner of CAD
or DNA fragmentation factor 40 (CAD/DFF40), respectively (24, 18). CAD has a DNase activity responsible for the degradation of
chromosomal DNA (24). Upon cleavage of ICAD, CAD catalyzes the cleavage of chromosomal DNA into nucleosomal fragments. Cleavage of
DFF45 releases DFF40, which has a low intrinsic DNase activity but is
thought to activate a nuclear DNase (18). Fragmentation of
DNA is not a requirement for cell death since inhibitors of caspase
activity block all caspase-dependent events, including the
fragmentation of DNA, but do not block the death of the cell (20,
29).
(ii) The death receptor-induced pathway may bypass the mitochondrial
regulation and directly engage the downstream effector, caspase-3.
Cytochrome c release, however, has recently been shown to amplify the effect of caspase-8 on the activation of downstream caspases (14, 19, 17). Studies of caspase
3
/
mice have shown that caspase-3 is required for
programmed cell death in the central nervous system and for the
nuclear events in apoptosis, chromatin condensation, and
DNA fragmentation (13, 28).
In the studies described here, we examined cells infected with wild
type or d120 mutant and cells infected and
subjected to osmotic shock for manifestations of activation of
programmed cell death. The events we examined were the outflow of
cytochrome c from the mitochondrial compartment, the
activation of caspase-3, and the oligonucleosomal degradation of DNA.
To induce osmotic shock, cells were exposed to high osmolar
concentrations of sorbitol. Osmotic shock activates multiple signalling
pathways (23) and induces a rapid response that allows for
the examination of different events in the execution of the cell death
program independently of the particular timing and kinetics of a
specific pathway. We report that d120 induces the release of
cytochrome into the cytosol and the depolarization of the inner
mitochondrial membrane. However, the fragmentation of the DNA that
marks the completion of the apoptotic process in
d120-infected cells appears to be a caspase-3-independent process consistent with the earlier finding that caspase inhibitors do
not block d120-induced DNA fragmentation. Wild-type HSV-1
appears to express functions that block multiple events in the
execution of the cell death program. This block is sufficient to
preclude apoptosis triggered both by expression of viral genes and by a caspase-dependent pathway triggered by osmotic shock-induced stress.
 |
MATERIALS AND METHODS |
Cells.
SK-N-SH and HEp-2 cell lines were obtained from
American Type Culture Collection and were grown in Dulbecco's
modification of Eagle minimal essential medium (DMEM) containing 5%
(HEp-2) or 10% fetal bovine serum (SK-N-SH).
Viruses.
HSV-1(F) is the prototype HSV-1 strain used in this
laboratory (8). The HSV-1 mutant d120 (a kind
gift of N. DeLuca) carries a deletion in both copies of the
4 gene
and was grown in a Vero cell line (E5) expressing the
4 gene
(6). It also carries a defective US3 gene
encoding a viral protein kinase (16).
Induction of apoptosis.
Osmotic shock was induced by
exposing SK-N-SH and HEp-2 cells that were mock infected or were
infected with 10 PFU of HSV-1(F) per cell either to 0.5 M sorbitol for
2 h or to 1.5 M sorbitol for 1 h, followed by 5 h of
incubation at 37°C in DMEM containing 1% newborn calf serum.
Measurement of caspase-3 activity.
Cellular extracts were
assayed for caspase-3 activity with a tetrapeptide conjugated
to phenylnitroaniline (DEVD-pNA). Briefly, 106 SK-N-SH
cells were either mock infected or were infected with 10 PFU of
HSV-1(F) or the d120 mutant per cell. At the indicated times
after infection, they were harvested, rinsed in
phosphate-buffered saline (PBS), resuspended in lysis buffer, and
stored on wet ice for 5 min. The lysates were then centrifuged at
10,000 × g for 10 min at 4°C. The supernatant fluids
were tested for caspase-3 activity as recommended by the manufacturer
by using the BIOMOL Quantizyme assay system. The released chromophore
was measured by determining the absorbance at 405 nm. The endpoint
reaction values shown correspond to the absorbance values obtained
at 280 min after the addition of the substrate.
Immunoblot assays.
Infected or uninfected cell lysates, each
containing approximately 60 µg of protein, were electrophoretically
separated in a 10% denaturing polyacrylamide gel, electrically
transferred onto a nitrocellulose sheet, and reacted with an
anti-poly(ADP-ribose) polymerase antibody (Santa Cruz Biotechnology) at
a concentration of 1 µg/ml. The protein bands reacting with the
antibody were visualized by using an enhanced chemiluminescence (ECL)
system (Pierce, Rockford, Ill.) as described for the localization of cytochrome c.
Subcellular fractionation.
Cells (4 × 106)
were either mock infected or were infected with 10 PFU of HSV-1(F) or
the HSV-1d120 mutant per cell. At the indicated times after
infection they were collected and resuspended in 0.8 ml of
ice-cold buffer A (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 250 mM sucrose, 0.1 mM TLCK
[N
-p-tosyl-L-lysine
chloromethyl ketone], 0.1 mM TPCK [tolylsulfonyl phenylalanyl
chloromethyl ketone]). After 15 min on ice, cells were homogenized in
a Dounce homogenizer and then centrifuged for 10 min at 750 × g in order to remove unlysed cells and nuclei. The supernatant
fluids were transferred to new tubes and centrifuged again at
10,000 × g per 20 min. Supernatant fluids from the
second centrifugation represent the cytosolic fractions, whereas the
pellets, resuspended in buffer A, represent the mitochondrial fractions.
Localization of cytochrome c.
The protein
concentration in mitochondrial and cytosolic fractions was determined
by using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules,
Calif.), according to the directions provided by the manufacturer.
Equivalent amounts of mitochondrial and cytosolic fractions were
subjected to electrophoresis in denaturing polyacrylamide gels,
transferred to nitrocellulose membranes, blocked in PBS (0.14 M NaCl, 3 mM KCl, 10 mM Na2HPO4, 1.5 mM
KH2PO4) containing 5% skim milk for 1 h
at room temperature or overnight at 4°C, rinsed three times in PBS,
and then reacted with the primary antibody against cytochrome
c, clone 7H8.2C12, (PharMingen, San Diego, Calif.), in a
solution of PBS containing 1 µg of the antibody per ml. The membranes
were then rinsed three times with PBS, reacted with a goat anti-mouse
antibody conjugated to peroxidase (Sigma, St. Louis, Mo.), rinsed
again, and visualized with the ECL system according to the protocols
provided by the manufacturers. Finally, filters were exposed to X-Omat
AR films (Kodak, Rochester, N.Y.) for the detection of specific bands.
Mitochondrial membrane potential measurement and flow
cytometry.
Subconfluent, uninfected cells or cells exposed to 10 PFU of HSV-1(F) or the d120 mutant per cell were collected,
rinsed in PBS, resuspended in 5 nM rhodamine-123 (Molecular Probes,
Eugene, Oreg.), and incubated at room temperature for 20 min. Cells
were then analyzed with a FACScan flow cytometer (Becton Dickinson) as
described previously (7) to detect changes in inner
mitochondrial membrane potential. Data from 2 × 104
cells were collected, stored, and analyzed by using Cellquest software
(Becton Dickinson). Ungated data are shown.
DNA fragmentation assay.
Subconfluent SK-N-SH cells were
mock infected or exposed to 10 PFU of HSV-1(F) or the d120
mutant per cell. Mock- or HSV-1(F)-infected cells were either left
untreated or exposed to 1 M sorbitol for 1 h; cells were then
incubated in DMEM containing 1% newborn calf serum for 5 h.
Samples containing 2 × 106 cells were collected and
processed as described earlier (10).
 |
RESULTS |
Infection does not induce activation of caspase-3.
The purpose
of the three series of experiments described below was to test the
hypothesis that infection of cells with the d120 mutant of
HSV-1 does not induce activation of caspase-3. The objective of the
first series of experiments was to determine whether the cells were
capable of inducing the activation of caspase-3 and to determine the
minimum amount of caspase-3 activity that correlates with activation of
the cell death program.
In the first series of experiments, SK-N-SH cells were exposed to
increasing concentrations of sorbitol in medium containing 1% fetal
bovine serum for 5 h. The lysates were assayed for specific DEVDase activity in colorimetric reactions as described in Materials and Methods. In preliminary studies it was determined that exposure of
cells to 0.25 M sorbitol was sufficient to induce apoptosis as
determined by DNA fragmentation, whereas exposure to 0.12 M sorbitol
was insufficient (data not shown). DEVD-pNA cleavage assays showed that
cytoplasmic lysates from cells exposed to 0.25 M sorbitol
exhibited 0.35 absorbance units at 405 nm, whereas the absorbance of
lysates from cells exposed to the lower concentration of sorbitol
could not be differentiated from that of the blank sample (Fig.
1).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
DEVDase activity in cells exposed to various
concentrations of sorbitol. SK-N-SH cells were exposed to various
concentrations of sorbitol as shown for 2 h and then incubated for
5 h in DMEM containing 1% fetal bovine serum. Cell extracts were
assayed for DEVDase activity as described in Materials and Methods. The
colorimetric reaction was monitored by measuring the absorbance at 405 nm. DNA fragmentation was observed only in cells treated with the two
highest concentrations tested (data not shown).
|
|
The purpose of the second series of experiments was to
compare the events occurring in cells exposed to sorbitol with those
occurring in cells infected with the
d120 mutant.
SK-N-SH cells
were mock infected, infected with 10 PFU of the
d120 mutant per
cell and incubated for 12 h, or exposed
to 0.25 M sorbitol for
5 h. At the same time after infection,
lysates from cells infected
by the
d120 mutant (Fig.
2, lane 1) or exposed to sorbitol (Fig.
2, lane 2) showed extensive DNA fragmentation, whereas cells exposed
to
wild-type virus alone or to both virus and sorbitol showed
little or no
degradation of DNA (Fig.
2, lanes 3 to 5). The lysates
collected in
parallel were tested for caspase-3 activity as described
above. The
DEVD-pNA cleavage assays yielded endpoint absorbance
values for lysates
from cells infected with the
d120 mutant that
were not
significantly higher than the values obtained for the
blank sample. In
contrast, lysates of cells exposed to sorbitol
yielded DEVD-ase
activities comparable to those obtained by the
addition of
purified recombinant caspase-3 to lysates from untreated
cells. This
activity was specific, as it could be completely inhibited
by the
simultaneous addition of the specific tetrapeptide aldehyde
inhibitor,
Ac-DEVD-CHO (Fig.
3).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 2.
Photograph of agarose gel containing electrophoretically
separated low-molecular-weight DNA fragments. SK-N-SH cells were mock
infected, exposed to sorbitol, infected with HSV-1(F) or d120 mutant,
or infected with HSV-1(F) and exposed to sorbitol as described in the
text. Cultures were mock infected or infected with 10 PFU of HSV-1(F)
or the d120 mutant per cell and collected 6 h
after infection. At 1 h after mock infection or infection
with 10 PFU of HSV-1(F) per cell, cells were exposed to 1 M sorbitol
for 1 h and incubated in DMEM containing 1% fetal bovine serum
for 5 h. Cell lysates were assayed for the presence of
oligonucleosomal DNA fragments as described in Materials and Methods.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Time course of DEVDase activity in cell extracts after
the addition of substrate. Extracts from infected or uninfected SK-N-SH
cells or from SK-N-SH cells exposed to sorbitol were assayed for
DEVDase activity at the indicated times after the addition of the
colorimetric substrate as described in Materials and Methods. The
colorimetric reaction was monitored by measuring the absorbance at 405 nm.
|
|
The third series of experiments was designed to test the
hypothesis that different inducers of apoptosis may trigger the
activation
of caspase-3 with different kinetics, and thus a peak of
DEVDase
activity could be transient and no longer present at the time
it was measured in lysates of cells infected with the
d120
mutant.
We therefore sought to precisely determine the timing of the
appearance
of caspase-3 activity in cells exposed to sorbitol or in
cells
infected with
d120. A time course analysis was done in
which cells
were simultaneously infected and exposed to sorbitol or
overlaid
with 0.5 M sorbitol and then collected at 2, 3, 7, 8, 12, or
20
h after infection or after exposure to sorbitol. No
caspase-3
activity, as measured by cleavage of the colorimetric
substrate,
was detected in mock-infected cells or in cells infected
with
wild-type or mutant HSV-1. In contrast, a peak of DEVDase
activity
was observed in cells exposed to osmotic shock at 2 to 3 h after
treatment. The DEVDase activity induced by
osmotic shock was completely
inhibited by the simultaneous
addition of the inhibitor Ac-DEVD-CHO
(Fig.
4).

View larger version (0K):
[in this window]
[in a new window]
|
FIG. 4.
Time course of DEVDase activity after exposure to
sorbitol, wild-type virus, or d120 mutant. SK-N-SH cells,
either mock infected or infected with HSV-1(F) or the d120
mutant or exposed to sorbitol in the presence or absence of the caspase
inhibitor Ac-DEVD-CHO were harvested at the times indicated in the
figure and assayed for DEVDase activity as described in Materials and
Methods. The colorimetric reaction was monitored by measuring the
absorbance at 405 nm. Endpoint values of absorbance are shown.
|
|
Infection does not block the cleavage of poly(ADP-ribose)
polymerase induced by osmotic shock.
To verify the absence of
caspase-3 activity, we examined the integrity of poly(ADP-ribose)
polymerase, one of its substrates. Caspase-3 is known to cleave the
Mr 110,000 poly(ADP-ribose) polymerase to yield
a truncated polypeptide with an Mr of 85,000. In
these experiments HEp-2 cells were infected with d120 (10 PFU/cell) and incubated for 12 h. Replicate cultures were exposed
to 0.25 M sorbitol at 1 h after mock infection or after infection
with wild-type or mutant viruses and were maintained for an
additional 2 or 5 h at 37°C. The results were as follows.
(i) The
Mr-85,000 cleavage product of the
poly(ADP-ribose) polymerase was detected in lysates of uninfected cells
exposed
to sorbitol for 2 or 5 h (Fig.
5A, lanes 4 and 6).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Photograph of electrophoretically separated cell lysates
reacted with an antibody to poly(ADP-ribose) polymerase. Lysates from
infected or uninfected HEp-2 cells either left untreated or exposed to
sorbitol were electrophoretically separated in a polyacrylamide gel,
transferred to a nitrocellulose sheet, and reacted with
antibody against poly(ADP-ribose) polymerase (PARP). (A) Cells were
treated with sorbitol at 1 h after infection and collected at 2 or
5 h after the addition of sorbitol. (B) Cells were treated at the
indicated times after infection and collected at 5 h after the
exposure to sorbitol.
|
|
(ii) Lysates of cells infected with either wild-type virus or
d120 exhibited trace amounts of
Mr-85,000 cleavage product (Fig.
5A, lane 3, and
5B, lane 2). The significance of the presence
of trace amounts of
cleaved poly(ADP-ribose) polymerase is unclear;
it could reflect a
small fraction of the cells in caspase-3 which
was activated as a
consequence of an abortive infection. The key
finding is that in
cells infected with either virus the vast majority
of the
poly(ADP-ribose) polymerase was intact, a finding consistent
with those
presented above and indicating that infection with
the
d120
mutant does not result in caspase-3 activation significantly
different
from that of the wild-type virus. At the same time after
infection, as
noted above, cells infected with the
d120 mutant
exhibit
extensive DNA fragmentation (Fig.
2, lane
1).
(iii) Poly(ADP-ribose) polymerase was cleaved in cells exposed to
sorbitol at 1 h after infection with wild-type virus (Fig.
5A,
lanes 5 and 7). It is noteworthy that cleavage was apparent
as early as
2 h after exposure of cells to
sorbitol.
To determine whether a function expressed later in infection could
block the activation of caspase-3, we repeated the same
experiment but
exposed the infected cells to sorbitol at 6, 12,
and 18 h after
infection. As shown in Fig.
5B, lanes 3 to 6, HSV-1
infection did not
preclude the cleavage of poly(ADP-ribose) polymerase
induced by osmotic
shock at any of the times tested. In contrast,
DNA fragmentation was
effectively blocked by wild-type HSV-1 in
cultures exposed to sorbitol
by as early as 1 h after infection
(Fig.
3 and
Fig.
2, lanes 2 and
3).
We should note that in the two experiments we detected larger
amounts of the poly(ADP-ribose) polymerase and of its cleavage
product
in the experiment illustrated in Fig.
5B than in the one
illustrated in
Fig.
5A. The relative amounts of intact and cleaved
product, however,
were comparable in both
experiments.
Outflow of cytochrome c from mitochondria in infected
cells.
In some pathways of apoptosis, the release of cytochrome
c precedes the activation of caspase-3 through the formation
of a complex that results in the activation of caspase-9, which can in
turn cleave and activate caspase-3. The absence of caspase-3 activity
in cells undergoing apoptosis induced by infection could be due to a
block in the release of cytochrome c into the
cytoplasm. To test this hypothesis, two series of experiments
were done. In the first, replicate HEp-2 cell cultures were mock
infected or were infected with wild-type virus [HSV-1(F)] or
d120 mutant. At 16.5 h after infection, one set of
cells was exposed to 0.5 M sorbitol in DMEM containing 5% newborn calf
serum for 1.5 h at 37°C. The cells were then harvested,
fractionated, and analyzed to determine the subcellular
distribution of cytochrome c as detailed in Materials
and Methods. The results (Fig. 6A)
were as follows. In cells mock infected or in cells infected with
HSV-1(F), cytochrome c was present in trace amounts and was
cofractionated mostly with the mitochondrial fraction (Fig. 6, lanes 1 to 4). In cells infected with the mutant d120, cytochrome
c increased in amount and was fractionated predominantly
with the cytosolic fraction (Fig. 6, lanes 5 and 6). As expected, in
mock-infected cells exposed to sorbitol, cytochrome c
increased in amount and was found predominantly in the cytosol
(Fig. 6, lanes 7 and 8). Virtually the same increase in cytochrome
c and prevalent localization in cytosol was observed in
cells infected with d120 mutant (Fig. 6, lanes 11 and 12). In contrast, in cells infected with wild-type virus and exposed to sorbitol, cytochrome c was localized in the mitochondria
(Fig. 6, lanes 8 and 9), indicating that a viral function can
block the release of cytochrome c into the cytoplasm
resulting from the induction of apoptosis by osmotic shock.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Immunoblot showing cytochrome c distribution
in mock-infected, infected, and sorbitol-treated HEp-2 cells. (A) HEp-2
cells were harvested at 16.5 h after mock infection or after
infection with viruses as indicated. Cells were exposed to sorbitol for
1.5 h. (B) HEp-2 cells were harvested at 4 h after mock
infection or after infection with viruses as indicated. Cells were
exposed to sorbitol for 1.5 h. The procedures were as described in
Materials and Methods. M, mitochondrial fraction; C, cytosol.
|
|
In the second series of experiments, replicate cultures of
HEp-2 cells were infected with HSV-1(F) or with the
d120 mutant.
At 2.5 h after infection, the medium
in one set of cells was replaced
with a medium containing 0.5 M
sorbitol, and the incubation was
continued for another 1.5 h at
37°C. The cells were harvested
and analyzed as described above. The
results, presented in Fig.
6B, were as follows. The total amount
of cytochrome
c detected
in both wild-type and
mutant-infected cells was significantly
lower than the amount detected
at 18 h after infection (compare
Fig.
6A with Fig.
6B) and,
moreover, the cytochrome that was detected
was associated with the
mitochondrial fraction. The significant
finding was that infection with
wild-type virus did not block
the release of cytochrome
c in
the cytosol of cells exposed to
sorbitol.
The studies shown in Fig.
6 indicate that the viral function which
blocks the release of cytochrome
c from the mitochondria
is
expressed between 1.5 and 16.5 h after infection. Other
studies
(data not shown) indicated that this function is
expressed before
12 h
postinfection.
Two comments should be made concerning the results presented in this
experiment. First, the increase in the amount of cytochrome
c detected in cells infected with wild-type virus and the
even
greater increase detected in cells undergoing programmed cell
death (e.g., mock-infected cells exposed to sorbitol or cells
infected
with the
d120 mutant) was reproducible. The data suggest
that either a fraction of cytochrome
c in unstressed cells
is
unavailable by the method of fractionation or that stress induces
the synthesis of cytochrome
c concomitantly with the
activation
of the cell death program, which would then be blocked in
cells
infected with wild-type virus. Second, in the experiment
shown
in Fig.
6, trace amounts of cytochrome
c could be
detected in
the cytoplasmic fraction of cells infected with wild-type
HSV-1
(lane 4), even though no fragmentation of DNA can be detected
in
any cell type tested so far. The presence of trace amounts
of
cytochrome
c in the cytoplasm of wild-type-infected cells
also
suggests the possibility that infection activates and then blocks
the execution of the cell death
program.
HSV-1(F) infection prevents the depolarization of the inner
mitochondrial membrane induced by osmotic shock.
The ability of
wild-type HSV-1 to prevent redistribution of cytochrome c
resulting from activation of the cell death program by osmotic shock
suggested that it could also be actively regulating other aspects of
mitochondrial function. We therefore investigated whether infection
could prevent the depolarization of the inner mitochondrial membrane,
an event that appears to be associated with some forms of programmed
cell death (reviewed in reference 22). In these
experiments, we compared the profile of rhodamine-123 (Rh-123)
fluorescence of mock-infected or HSV-1(F)-infected cells that were
either left untreated or were exposed to sorbitol. Approximately 45%
of the mock-infected cells exposed to sorbitol showed a decreased mitochondrial membrane potential compared to untreated or
HSV-1(F)-infected cells (Fig. 7, compare
panel B with panels A and C). In contrast, HSV-1(F)-infected cells
treated by osmotic shock showed no detectable increase in the
percentage of depolarized cells (Fig. 7D). Infection therefore prevents
the loss of inner mitochondrial membrane potential resulting from
induction of apoptosis by osmotic shock.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 7.
Distribution of cells according to their Rh-123
fluorescence intensities. (A) Rh-123 fluorescence profiles of
mock-infected or HSV-1(F)-infected cells either left untreated or
exposed to sorbitol. (B) Rh-123 fluorescence profiles of
HSV-1(F)-infected or d120-infected HEp-2 cells at 12 and
24 h after infection. The thicker line corresponds to the profile
of uninfected cells and is shown as a reference.
|
|
Depolarization of the inner mitochondrial membrane in
d120-infected cells.
The data presented above showed
that the d120 mutant induced the release of cytochrome
c into cytosol. To determine whether d120
infection could also induce the loss of inner mitochondrial potential,
we examined the Rh-123 fluorescence profiles of cells at 12 and 24 h after infection with either HSV-1(F) or the d120 mutant.
At 12 h after infection, neither HSV-1(F)- nor
d120-infected cells showed any detectable decrease in Rh-123
fluorescence (Fig. 7E and G). At 24 h after infection, however,
cells infected with the d120 mutant show a marked decrease
in Rh-123 fluorescence intensity, indicating a loss in their inner
mitochondrial membrane potential (Fig. 7F).
 |
DISCUSSION |
The current model of programmed cell death delineates two major
pathways connecting different apoptotic stimuli with the activation of
a family of cysteine proteases called caspases that mediate the
organized dismemberment of the cell (reviewed in reference 4). In the case of signalling through death
receptors, the proteolytic machinery is engaged directly; in the case
of pathways activated by stress, the signal to activate the proteolytic
cascade is regulated at the level of mitochondria by members of the
Bcl-2 family of proteins (reviewed in reference 1).
Both pathways converge in the activation of downstream effector
caspase-3, -6, and -7, which are responsible for the
morphological features of apoptosis such as membrane blebbing,
chromatin condensation, and DNA fragmentation. In particular, it was
shown that caspase-3 is directly linked to the activation of the
endonuclease that mediates the fragmentation of chromosomal DNA
(24, 28). Our interest in programmed cell death in
relation to HSV-1 infection stemmed from two observations: (i) that
mutants of HSV-1 induce apoptosis and (ii) that infection with the
d120 mutant causes DNA fragmentation that cannot be blocked
by caspase inhibitors. The experimental objectives of the studies
described in this study were to identify the manifestations of the
programmed cell death blocked by wild-type virus. We examined
cells that were infected with wild-type virus or d120
mutant, exposed to sorbitol, or both infected and exposed to sorbitol
for the activation of caspase-3, the release of cytochrome c
into cytosol, the depolarization of the inner mitochondrial membrane,
and the fragmentation of DNA. The salient features of the results
summarized in Fig. 8 were as follows.

View larger version (0K):
[in this window]
[in a new window]
|
FIG. 8.
Schematic representation of the manifestations of the
programmed cell death assayed in these studies. "Yes" and "no"
refer to detection of or failure to detect, respectively,
manifestations of intracellular events associated with programmed cell
death.
|
|
(i) No caspase-3 activity could be detected in cells infected with the
d120 mutant, even though d120 induced the release
of cytochrome c into cytosol, depolarization of the inner
mitochondrial membrane, and extensive fragmentation of chromosomal DNA.
Consistent with these results, as reported earlier, caspase inhibitors
failed to block the fragmentation of DNA induced by infection with the d120 mutant. We conclude that the pathway of programmed cell
death induced by the d120 mutant of HSV-1 is caspase
3-independent.
(ii) As expected, osmotic shock resulting from the exposure of
uninfected cells to sorbitol induced cytochrome c release, activation of caspase-3, depolarization of the inner mitochondrial membrane, and degradation of chromosomal DNA. The activation of caspase-3 and DNA fragmentation were blocked by caspase inhibitors.
(iii) In cells infected with wild-type HSV-1 and exposed to sorbitol,
cytochrome c release, depolarization of the inner
mitochondrial membrane, and fragmentation of DNA were blocked.
These results lead to several significant conclusions. First, the
evidence unambiguously indicates that cells infected with d120 succumbed to caspase-3-independent programmed cell
death. The evidence that no manifestations of apoptosis were seen in cells infected with wild-type HSV-1 indicate that the wild-type virus
can express functions that block this pathway.
Second, the evidence that cells exposed to sorbitol
succumbed to a caspase-3-dependent programmed cell death that is
blocked by the wild-type virus indicates that the virus expresses
functions that can block this pathway.
Third, the evidence that in infected cells exposed to sorbitol
caspase-3 was not blocked has two significant implications. Foremost, HSV-1 may not have evolved functions that block
caspase-3 but rather has functions that block a subsequent step, that
is, the fragmentation of DNA. Implicit in this conclusion is that the
virus evolved a mechanism to block specifically DNA fragmentation and
that none of the substrates of caspase-3 are of vital importance to the
virus. Of equal significance, the evidence that HSV-1
infection precluded cytochrome c release and DNA
fragmentation but not caspase-3 activation indicates that the virus
blocks the cascade of events leading to programmed cell death at
several steps independently.
The studies described here were done with HEp-2 and SK-N-SH cells. The
response of these two cell lines to infection or sorbitol and,
conversely, the effectiveness of viral gene expression in response to
apoptotic events initiated in these cell lines were equivalent. In an
earlier publication from this laboratory (10), it has been
shown that the response may be cell type dependent. For example,
SK-N-SH cells were protected by wild-type virus from the effects of a
variety of exogenous inducers of apoptosis, whereas HeLa cells treated
in the same fashion were not. Similarly, tsB7 at the
nonpermissive temperature induced apoptosis in Vero cells but not in
SK-N-SH cells. The possibility that Vero cells may respond to wild-type
infection in a manner different from that of HEp-2 cells is suggested
by the report that mitochondrial RNA polymerase could be found in the
cytosolic fraction of Vero cells infected with wild-type virus
(27).
The model that emerges from this and preceding studies is that HSV
replication occurs in a very hostile environment in which the cells are
programmed to respond to stimuli from the invading virus and from
exogenous sources (e.g., the immune system) to commit suicide in order
to preclude the invader from taking hold. The apoptotic stimuli from
the invading virus appear to occur at several steps in its reproductive
cycle, most probably from the moment of its interaction with the host
cell. Pari passu, the virus expresses functions necessary to block the
activation of the programmed cell death to ensure that the
infected cells are totally subservient to its needs and to maximize
viral progeny. Coevolution of the virus and the host may have led to
the acquisition of functions that block not only the apoptotic pathway
induced by the virus but also those induced by external activators such as the immune system of the host. Identification of the various functions expressed by the virus to block these pathways is a major
objective for three reasons. First, this will identify the viral
biochemical events that could lead to programmed cell death. Second, it
may yield clues to interventions that nullify viral blocks to apoptosis
in order to curtail infection at a critical step. Finally,
identification of viral functions that block individual steps in
programmed cell death may lead to applications in areas in which
blockage of apoptosis is therapeutically desirable.
 |
ACKNOWLEDGMENTS |
We thank Julie Auger for assistance with flow cytometry.
These studies were aided by grants from the National Cancer Institute
(CA47451, CA71933, and CA78766). The Flow Cytometry Core Facility is
supported by grants CA-14599 and DK49799 from the NCI and NIDDK. V.G.
is a Markey postdoctoral fellow.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: The University
of Chicago, 910 E. 58th St., Chicago, IL 60637. Phone: (773) 702-1898. Fax: (773) 702-1631. E-mail:
bernard{at}cummings.uchicago.edu.
 |
REFERENCES |
| 1.
|
Adams, J., and S. Cory.
1998.
The Bcl-2 protein family: arbiters of cell survival.
Science
281:1322-1326[Abstract/Free Full Text].
|
| 2.
|
Batterson, W.,
D. Furlong, and B. Roizman.
1985.
Molecular genetics of herpes simplex virus. VIII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle.
J. Virol.
54:397-407.
|
| 3.
|
Batterson, W., and B. Roizman.
1983.
Characterization of the herpes simplex virion-associated factor responsible for the induction of genes.
J. Virol.
46:371-377[Abstract/Free Full Text].
|
| 4.
|
Cory, S.
1998.
Cell death throes.
Proc. Natl. Acad. Sci. USA
95:12077-12079[Free Full Text].
|
| 5.
|
Cryns, V., and J. Yuan.
1998.
Proteases to die for.
Genes Dev.
12:1551-1570[Free Full Text].
|
| 6.
|
DeLuca, N. A.,
A. McCarth, and P. A. Schaffer.
1985.
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.
J. Virol.
56:558-570[Abstract/Free Full Text].
|
| 7.
|
Derfuss, T.,
H. Fickenscher,
M. S. Kraft,
G. Henning,
D. Lengenfelder,
B. Fleckenstein, and E. Meinl.
1998.
Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activity.
J. Virol.
72:5897-5904[Abstract/Free Full Text].
|
| 8.
|
Ejercito, P. M.,
E. D. Kieff, and B. Roizman.
1968.
Characterization of herpes simplex virus strains differing in their effects on social behavior of infected cells.
J. Gen. Virol.
2:357-364[Abstract/Free Full Text].
|
| 9.
| Reference deleted.
|
| 10.
|
Galvan, V., and B. Roizman.
1998.
Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner.
Proc. Natl. Acad. Sci. USA
95:3931-3936[Abstract/Free Full Text].
|
| 11.
|
Jerome, K.,
J. F. Tait,
D. M. Koelle, and L. Corey.
1998.
Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte induced apoptosis.
J. Virol.
72:436-441[Abstract/Free Full Text].
|
| 12.
|
Koyama, A. H., and Y. Miwa.
1997.
Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells.
J. Virol.
71:2567-2571[Abstract].
|
| 13.
|
Kuida, K.,
T. S. Zheng,
S. Na,
C. Kuan,
D. Yang,
H. Karasuyama,
P. Rakic, and R. Flavell.
1996.
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.
Nature
384:368-372[Medline].
|
| 14.
|
Kuwana, T.,
J. J. Smith,
M. Muzio,
V. Dixit,
D. D. Newmeyer, and S. Kornbluth.
1998.
Apoptosis induction by caspase-8 is amplified through mitochondrial release of cytochrome C.
J. Biol. Chem.
273:16589-16594[Abstract/Free Full Text].
|
| 15.
|
Leopardi, R., and B. Roizman.
1996.
The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia.
Proc. Natl. Acad. Sci. USA
93:9583-9587[Abstract/Free Full Text].
|
| 16.
|
Leopardi, R.,
C. Van Sant, and B. Roizman.
1997.
The herpes simplex virus 1 protein kinase US3 is required for protection induced by the virus.
Proc. Natl. Acad. Sci. USA
94:7891-7896[Abstract/Free Full Text].
|
| 17.
|
Li, H.,
H. Zhu,
C. Xu, and J. Yuan.
1998.
Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis.
Cell
94:491-501[Medline].
|
| 18.
|
Liu, S.,
H. Zou,
C. Slaughter, and X. Wang.
1997.
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.
Cell
89:175-184[Medline].
|
| 19.
|
Luo, X.,
I. Budihardjo,
H. Zou,
C. Slaughter, and X. Wang.
1998.
Bid, a Blc-2 interacting protein mediates cytochrome C release from mitochondria in response to activation of cell surface death receptors.
Cell
94:481-490[Medline].
|
| 20.
|
McCarthy, N. J.,
M. K. B. Whyte,
C. S. Gilbert, and G. I. Evan.
1997.
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak.
J. Cell Biol.
136:215-227[Abstract/Free Full Text].
|
| 21.
|
Muzio, M.,
A. M. Chinnaiyan,
F. C. Kischkel,
K. O'Rourke,
A. Shevshenko,
J. Ni,
C. Scaffidi,
J. D. Bretz,
M. Zhang,
R. Gentz,
M. Mann,
P. H. Krammer,
M. E. Peter, and V. M. Dixit.
1996.
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex.
Cell
85:817-827[Medline].
|
| 22.
|
Reed, J.
1997.
Cytochrome C: can't live with it, can't live without it.
Cell
91:559-562[Medline].
|
| 23.
|
Rosette, C., and M. Karin.
1996.
Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factors and cytokine receptors.
Science
274:1194-1197[Abstract/Free Full Text].
|
| 24.
|
Sakahira, H.,
M. Enari, and S. Nagata.
1998.
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis.
Nature
391:96-99[Medline].
|
| 25.
|
Salvesen, G. S., and V. Dixit.
1997.
Caspases: intracellular signaling by proteolysis.
Cell
91:443-446[Medline].
|
| 26.
|
Thornberry, N. A., and Y. Lazebnik.
1998.
Caspases: enemies within.
Science
281:1312-1316[Abstract/Free Full Text].
|
| 27.
|
Tsurumi, T., and I. R. Lehman.
1990.
Release of RNA polymerase from Vero cell mitochondria after herpes simplex virus type 1 infection.
J. Virol.
64:450-452[Abstract/Free Full Text].
|
| 28.
|
Woo, M.,
R. Hakem,
M. S. Soengas,
G. S. Duncan,
A. Shahinian,
D. Kagi,
A. Hakem,
M. McCurrach,
W. Khoo,
S. A. Kaufman,
G. Senaldi,
T. Howard,
S. W. Lowe, and T. W. Mak.
1998.
Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes.
Genes Dev.
12:806-819[Abstract/Free Full Text].
|
| 29.
|
Xiang, J.,
D. T. Chao, and S. J. Korsmeyer.
1996.
Bax-induced cell death may not require interleukin 1 -converting enzyme-like proteases.
Proc. Natl. Acad. Sci. USA
93:14559-14563[Abstract/Free Full Text].
|
| 30.
|
Zou, H.,
W. J. Henzel,
X. Liu,
A. Lutschg, and X. Wang.
1997.
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.
Cell
90:405-413[Medline].
|
Journal of Virology, April 1999, p. 3219-3226, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shen, W., Sa e Silva, M., Jaber, T., Vitvitskaia, O., Li, S., Henderson, G., Jones, C.
(2009). Two Small RNAs Encoded within the First 1.5 Kilobases of the Herpes Simplex Virus Type 1 Latency-Associated Transcript Can Inhibit Productive Infection and Cooperate To Inhibit Apoptosis. J. Virol.
83: 9131-9139
[Abstract]
[Full Text]
-
Benetti, L., Roizman, B.
(2007). In Transduced Cells, the US3 Protein Kinase of Herpes Simplex Virus 1 Precludes Activation and Induction of Apoptosis by Transfected Procaspase 3. J. Virol.
81: 10242-10248
[Abstract]
[Full Text]
-
Miles, D. H., Thakur, A., Cole, N., Willcox, M. D. P.
(2007). The Induction and Suppression of the Apoptotic Response of HSV-1 in Human Corneal Epithelial Cells. IOVS
48: 789-796
[Abstract]
[Full Text]
-
Benetti, L., Roizman, B.
(2006). Protein Kinase B/Akt Is Present in Activated Form throughout the Entire Replicative Cycle of {Delta}US3 Mutant Virus but Only at Early Times after Infection with Wild-Type Herpes Simplex Virus 1.. J. Virol.
80: 3341-3348
[Abstract]
[Full Text]
-
Schaap, A., Fortin, J.-F., Sommer, M., Zerboni, L., Stamatis, S., Ku, C.-C., Nolan, G. P., Arvin, A. M.
(2005). T-Cell Tropism and the Role of ORF66 Protein in Pathogenesis of Varicella-Zoster Virus Infection. J. Virol.
79: 12921-12933
[Abstract]
[Full Text]
-
Wiegand, M., Bossow, S., Neubert, W. J.
(2005). Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner. J. Gen. Virol.
86: 2305-2314
[Abstract]
[Full Text]
-
Peng, W., Henderson, G., Inman, M., BenMohamed, L., Perng, G.-C., Wechsler, S. L., Jones, C.
(2005). The Locus Encompassing the Latency-Associated Transcript of Herpes Simplex Virus Type 1 Interferes with and Delays Interferon Expression in Productively Infected Neuroblastoma Cells and Trigeminal Ganglia of Acutely Infected Mice. J. Virol.
79: 6162-6171
[Abstract]
[Full Text]
-
Taddeo, B., Zhang, W., Lakeman, F., Roizman, B.
(2004). Cells Lacking NF-{kappa}B or in Which NF-{kappa}B Is Not Activated Vary with Respect to Ability To Sustain Herpes Simplex Virus 1 Replication and Are Not Susceptible to Apoptosis Induced by a Replication-Incompetent Mutant Virus. J. Virol.
78: 11615-11621
[Abstract]
[Full Text]
-
Benetti, L., Roizman, B.
(2004). Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. USA
101: 9411-9416
[Abstract]
[Full Text]
-
Jones, C. A., Fernandez, M., Herc, K., Bosnjak, L., Miranda-Saksena, M., Boadle, R. A., Cunningham, A.
(2003). Herpes Simplex Virus Type 2 Induces Rapid Cell Death and Functional Impairment of Murine Dendritic Cells In Vitro. J. Virol.
77: 11139-11149
[Abstract]
[Full Text]
-
Peng, W., Henderson, G., Perng, G.-C., Nesburn, A. B., Wechsler, S. L., Jones, C.
(2003). The Gene That Encodes the Herpes Simplex Virus Type 1 Latency-Associated Transcript Influences the Accumulation of Transcripts (Bcl-xL and Bcl-xS) That Encode Apoptotic Regulatory Proteins. J. Virol.
77: 10714-10718
[Abstract]
[Full Text]
-
Medici, M. A., Sciortino, M. T., Perri, D., Amici, C., Avitabile, E., Ciotti, M., Balestrieri, E., De Smaele, E., Franzoso, G., Mastino, A.
(2003). Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis: ROLE OF NUCLEAR FACTOR {kappa}B. J. Biol. Chem.
278: 36059-36067
[Abstract]
[Full Text]
-
Benetti, L., Munger, J., Roizman, B.
(2003). The Herpes Simplex Virus 1 US3 Protein Kinase Blocks Caspase-Dependent Double Cleavage and Activation of the Proapoptotic Protein BAD. J. Virol.
77: 6567-6573
[Abstract]
[Full Text]
-
Lovato, L., Inman, M., Henderson, G., Doster, A., Jones, C.
(2003). Infection of Cattle with a Bovine Herpesvirus 1 Strain That Contains a Mutation in the Latency-Related Gene Leads to Increased Apoptosis in Trigeminal Ganglia during the Transition from Acute Infection to Latency. J. Virol.
77: 4848-4857
[Abstract]
[Full Text]
-
Jones, C.
(2003). Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency. Clin. Microbiol. Rev.
16: 79-95
[Abstract]
[Full Text]
-
Bitzer, M., Armeanu, S., Prinz, F., Ungerechts, G., Wybranietz, W., Spiegel, M., Bernlohr, C., Cecconi, F., Gregor, M., Neubert, W. J., Schulze-Osthoff, K., Lauer, U. M.
(2002). Caspase-8 and Apaf-1-independent Caspase-9 Activation in Sendai Virus-infected Cells. J. Biol. Chem.
277: 29817-29824
[Abstract]
[Full Text]
-
Zhou, G., Roizman, B.
(2002). Cation-Independent Mannose 6-Phosphate Receptor Blocks Apoptosis Induced by Herpes Simplex Virus 1 Mutants Lacking Glycoprotein D and Is Likely the Target of Antiapoptotic Activity of the Glycoprotein. J. Virol.
76: 6197-6204
[Abstract]
[Full Text]
-
Ahmed, M., Lock, M., Miller, C. G., Fraser, N. W.
(2002). Regions of the Herpes Simplex Virus Type 1 Latency-Associated Transcript That Protect Cells from Apoptosis In Vitro and Protect Neuronal Cells In Vivo. J. Virol.
76: 717-729
[Abstract]
[Full Text]
-
Munger, J., Roizman, B.
(2001). The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. USA
10.1073/pnas.181344498v1
[Abstract]
[Full Text]
-
Zhou, G., Roizman, B.
(2001). The Domains of Glycoprotein D Required To Block Apoptosis Depend on Whether Glycoprotein D Is Present in the Virions Carrying Herpes Simplex Virus 1 Genome Lacking the Gene Encoding the Glycoprotein. J. Virol.
75: 6166-6172
[Abstract]
[Full Text]
-
Munger, J., Chee, A. V., Roizman, B.
(2001). The US3 Protein Kinase Blocks Apoptosis Induced by the d120 Mutant of Herpes Simplex Virus 1 at a Premitochondrial Stage. J. Virol.
75: 5491-5497
[Abstract]
[Full Text]
-
Inman, M., Perng, G.-C., Henderson, G., Ghiasi, H., Nesburn, A. B., Wechsler, S. L., Jones, C.
(2001). Region of Herpes Simplex Virus Type 1 Latency-Associated Transcript Sufficient for Wild-Type Spontaneous Reactivation Promotes Cell Survival in Tissue Culture. J. Virol.
75: 3636-3646
[Abstract]
[Full Text]
-
Zachos, G., Koffa, M., Preston, C. M., Clements, J. B., Conner, J.
(2001). Herpes Simplex Virus Type 1 Blocks the Apoptotic Host Cell Defense Mechanisms That Target Bcl-2 and Manipulates Activation of p38 Mitogen-Activated Protein Kinase To Improve Viral Replication. J. Virol.
75: 2710-2728
[Abstract]
[Full Text]
-
DeBiasi, R. L., Edelstein, C. L., Sherry, B., Tyler, K. L.
(2001). Calpain Inhibition Protects against Virus-Induced Apoptotic Myocardial Injury. J. Virol.
75: 351-361
[Abstract]
[Full Text]
-
Zhou, G., Galvan, V., Campadelli-Fiume, G., Roizman, B.
(2000). Glycoprotein D or J Delivered in trans Blocks Apoptosis in SK-N-SH Cells Induced by a Herpes Simplex Virus 1 Mutant Lacking Intact Genes Expressing Both Glycoproteins. J. Virol.
74: 11782-11791
[Abstract]
[Full Text]
-
Zhou, G., Roizman, B.
(2000). Wild-Type Herpes Simplex Virus 1 Blocks Programmed Cell Death and Release of Cytochrome c but Not the Translocation of Mitochondrial Apoptosis-Inducing Factor to the Nuclei of Human Embryonic Lung Fibroblasts. J. Virol.
74: 9048-9053
[Abstract]
[Full Text]
-
Coukos, G., Makrigiannakis, A., Kang, E. H., Rubin, S. C., Albelda, S. M., Molnar-Kimber, K. L.
(2000). Oncolytic Herpes Simplex Virus-1 Lacking ICP34.5 Induces p53-independent Death and Is Efficacious against Chemotherapy-resistant Ovarian Cancer. Clin. Cancer Res.
6: 3342-3353
[Abstract]
[Full Text]
-
Eléouët, J.-F., Slee, E. A., Saurini, F., Castagné, N., Poncet, D., Garrido, C., Solary, E., Martin, S. J.
(2000). The Viral Nucleocapsid Protein of Transmissible Gastroenteritis Coronavirus (TGEV) Is Cleaved by Caspase-6 and -7 during TGEV-Induced Apoptosis. J. Virol.
74: 3975-3983
[Abstract]
[Full Text]
-
Herbein, G., O'brien, W. A.
(2000). Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis. Exp. Biol. Med.
223: 241-257
[Abstract]
[Full Text]
-
Perng, G., Jones, C., Ciacci-Zanella, J., Stone, M., Henderson, G., Yukht, A., Slanina, S. M., Hofman, F. M., Ghiasi, H., Nesburn, A. B., Wechsler, S. L.
(2000). Virus-Induced Neuronal Apoptosis Blocked by the Herpes Simplex Virus Latency-Associated Transcript. Science
287: 1500-1503
[Abstract]
[Full Text]
-
Galvan, V., Brandimarti, R., Munger, J., Roizman, B.
(2000). Bcl-2 Blocks a Caspase-Dependent Pathway of Apoptosis Activated by Herpes Simplex Virus 1 Infection in HEp-2 Cells. J. Virol.
74: 1931-1938
[Abstract]
[Full Text]
-
Aubert, M., O'Toole, J., Blaho, J. A.
(1999). Induction and Prevention of Apoptosis in Human HEp-2 Cells by Herpes Simplex Virus Type 1. J. Virol.
73: 10359-10370
[Abstract]
[Full Text]
-
Jerome, K. R., Fox, R., Chen, Z., Sears, A. E., Lee, H.-y., Corey, L.
(1999). Herpes Simplex Virus Inhibits Apoptosis through the Action of Two Genes, Us5 and Us3. J. Virol.
73: 8950-8957
[Abstract]
[Full Text]
-
Khodarev, N. N., Advani, S. J., Gupta, N., Roizman, B., Weichselbaum, R. R.
(1999). Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc. Natl. Acad. Sci. USA
96: 12062-12067
[Abstract]
[Full Text]
-
Munger, J., Roizman, B.
(2001). The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. USA
98: 10410-10415
[Abstract]
[Full Text]